Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients

Aarogyam UK

Status: Completed

Conditions: Asymptomatic Condition; Covid19

Treatments: Drug: Guduchi Ghan Vati

Study type: Observational

Funder types: Other

Identifiers

NCT04480398

AYU/DSSR/02

Details and patient eligibility

About

Coronavirus disease 2019 (Covid-19) has been declared global emergency with immediate safety, preventative and curative measures to control the spread of virus. Confirmed cases are treated with clinical management as they are diagnosed but so far, there is no effective treatment or vaccine yet for Covid-19.

With recommended guidelines of AYUSH Ministry, India, the use of Ayurveda for Covid-19 has increased; however, its efficacy and safety in Covid-19 confirmed patients remain unclear.

Present study examined the efficacy and safety of one of the recommended Ayurveda drug (Guduchi Ghan Vati) compared with standard care for patients with asymptomatic Covid-19 patients.

Enrollment: 91 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age over 18
• A person diagnosed with COVID-19
• Asymptomatic at the time of admission

Exclusion criteria

• Patients over 75 years
• Taking antibiotics or antiretroviral for any reason
• Mild to Moderate symptoms at the time of hospital admission

Trial design

91 participants in 2 patient groups

Ayurveda

Description:

Guduchi Ghan Vati was given to Covid patients 2 tablets (500 mg each) twice daily were given orally after meal for 28 days. Guduchi ghan vati is a powdered aqueous extract of Tinospora cordifolia in tablet form and prepared in GMP certified Pharmacy of the University, following standard protocol.

Treatment:

Drug: Guduchi Ghan Vati

Control

Description:

Standard care for asymptomatic confirmed cases is isolation (to contain virus transmission) and clinical monitoring as per recommended Guidelines.